Up Over 100% in 2026, Is CrowdStrike Still a Buy?

CrowdStrike shares have risen more than 100% in 2026, while fiscal 2027 Q2 annual recurring revenue grew 25% year over year and revenue increased 26%; analysts project 23% revenue growth next year. The article argues the stock is near its highest-ever price-to-sales valuation despite slower growth than when it reached its prior valuation peak in late 2021, and recommends shareholders consider taking some gains.

Analysis

CRWD’s vulnerability is not that cybersecurity demand is weakening; it is that investors may be paying upfront for durable growth and successful monetization of AI-related threat demand. AI is a two-sided force: more sophisticated attacks can increase the value of integrated protection, but cheaper attack tools also invite new vendors and make platform bundling by Palo Alto Networks and other established rivals more consequential. The key proof point is whether broader module adoption converts into sustained net retention, pricing power, and improving cash generation—not product count alone.

Near term (days to weeks), after a sharp rerating, the stock is exposed to profit-taking and any disappointment against elevated expectations; the article supplies no valuation multiple, implied growth assumptions, or current consensus detail, so the degree of excess cannot be quantified here. Over 1–3 months, monitor ARR growth, net new ARR, retention/upsell indicators, and guidance for evidence that growth is reaccelerating enough to support the premium. Over 6–18 months, the central risk is multiple compression if growth moderates before profitability and cash conversion become more durable. The contrarian case is credible: strong customer expansion and persistent security needs could sustain premium economics, and a high multiple alone is not a timing signal.

Key Decisions for Investors

• Avoid chasing CRWD after the run-up. For existing holders, consider trimming to a predefined position limit rather than making a full exit solely on valuation concerns.
• Relative-value watch: consider a modest CRWD underweight against a diversified cybersecurity exposure only if current valuation work confirms CRWD is priced for materially faster growth than peers. Do not implement before checking peer growth, valuation, and cash-flow comparisons; no peer ticker mapping is supplied here.
• Catalyst check over the next 1–3 months: track ARR and net new ARR growth, customer retention and module expansion, guidance, and free-cash-flow conversion. Stronger growth plus improving cash generation would weaken the de-rating thesis; slowing ARR or weaker guidance would strengthen it.
• Falsification: reassess an underweight if CRWD sustains growth acceleration and demonstrates improving profitability/cash conversion without relying on valuation expansion. Conversely, a material slowdown in ARR or reduced guidance would support further downside-risk management.